Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Functional Brain Imaging and Employment in First-Episode Psychotic Patients Treated With Risperdal

This study has been terminated.
Sponsor:
Collaborator:
Janssen, LP
Information provided by:
Duke University
ClinicalTrials.gov Identifier:
NCT00314613
First received: April 12, 2006
Last updated: June 19, 2013
Last verified: May 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: December 2006 (Final data collection date for primary outcome measure)